Enquire Now
Enquire Apply

Dr. Rupasree Peruru View All

Assistant Professor

Apollo Institute of Pharmaceutical Sciences

Dr. Rupasree earned her B. Pharmacy degree from Sri Padmavati Mahila Visvavidyalayam, Tirupati, and completed her postgraduate studies in Pharmacology and Toxicology at the National Institute of Pharmaceutical Education and Research, Hyderabad. She obtained her Ph.D. in Neuropharmacology from Sri Padmavati Mahila Visvavidyalayam, Tirupati.

With over a year of experience as an Academic Consultant at Sri Padmavati Mahila Visvavidyalayam, Dr. Rupasree has published six articles in national and international journals and holds two patents. She has also authored two books/e-books for students published by Walnut and Elsevier.

    • Graduation In :

      B. PHARMACY

    • Graduation From :

      Sri Padmavati Mahila Visvavidyalayam

    • Graduation Year :

      2012

    • Post Graduation In :

      MS (PHARM) in Pharmacology and Toxicology

    • Post Graduation From :

      National Institute of Pharmaceutical Education and Research (NIPER) – Hyderabad

    • Post Graduation Year :

      2014

    • Doctorate In :

      Pharmacology

    • Doctorate From :

      Sri Padmavati Mahila Visvavidyalayam

    • Doctorate Year :

      2023

    • 1 year of teaching experience as an academic consultant at Sri Padmavati Mahila Visvavidyalayam

  • Book Chapters

    • Sireesha Guttapalam, Rupasree Peruru and Jhansirani Thatiparthy; Metabolic Syndrome its complications and Treatment Therapeutic Interventions” is accepted for book publication – Nutrition Health and Well-being.
    • D. Sujatha, P. Rupasree, S. Sunitha, KVSRG. Prasad; Citrus Flavonoids – Mechanisms of Neuroprotection and Preclinical Evidence – Natural Molecules in Neuroprotection and Neurotoxicity Elsevier publications, ISBN: 9780323951180, edited by Marcos de Olivier.

    Publications in Journals

    • Rupasree Peruru, Sujatha Dodoala; Therapeutic potential of diosmin, a citrus flavonoid against arsenic induced neurotoxicity via suppression of NOX 4 and its subunits; Indian Jounrnal of Pharmacology (IJP); 2021; 53:132-42.
    • Rupasree Peruru, Usha Rani R, Jhansyrani Thatiparthi, Sunitha Sampathi, Sujatha Dodoala, Prasad KVSRG; Devil’s claw (harpagophytum procumbens) ameliorates the neurobehavioral changes and neurotoxicity in female rats exposed to arsenic; Heliyon; 2020; e 03921.
    • Rupasree Peruru, and Sujatha Dodoala; In silico predictions of NADPH oxidase binding properties of selected flavonoids – Protective role in arsenic induced neurotoxicity; International Journal of Research in Pharmaceutical Sciences; 2022, 13(3), 267-281.
    • Rupasree Peruru, Siva Swapna kasarla, Palla Hymavathi and Sujatha Dodoala; Flavonoid Hesperidin Attenuates the Neurobehavioral Changes and Neurotoxicity caused due to Arsenic by Inhibiting NOX 4 Expression; High Technology Letters; Volume 27, Issue 11, 2021.
    • T. Jhansyrani, D. Sujatha, P. Rupasree, K. Bharathi and K. V. S. R. G. Prasad; In-vitro Antioxidant Potential of Selected Nutraceuticals; International Journal of Pharmaceutical Sciences and Research, 2019; Vol. 10(3): 1426-1432.

    Publications in Conferences

    • Rupasree Peruru and Sujatha Dodoala; Protective effect of Naringenin against Arsenic trioxide induced oxidative stress; The FASEB Journal 31, lb565-lb565.

  • Patents

    • “A System and Method For Optimizing Assessment Of NADPH Oxidase Enzyme” Application number 202341077693 –Granted.
    • “Implanted Microchip Device for Personalized Drug Delivery In Diabetes Management”- German patent